
CHC’s Yuanbin Chen, MD is a contributing author in the Journal of Thoracic Oncology’s article “Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study”.
CHC’s Yuanbin Chen, MD is a contributing author in the Journal of Thoracic Oncology’s article “Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study”.